Showing results (31-40 of 374) with videos related to

Sort By:
Pageof 38
Annals of the New York Academy of Sciences|September 26, 2007
Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndromeI Krause, M Blank, R Cervera, et al.
Autoimmunity Reviews|December 2, 2006
The catastrophic antiphospholipid (Asherson's) syndrome and malignanciesW Miesbach, R A Asherson, R Cervera, et al.
Medicina Clinica|May 3, 1997
[Primary Sjögren's syndrome: clinical and immunologic study of 80 patients]M Ramos, R Cervera, M García-Carrasco, et al.
Lupus|June 2, 1998
Young onset of primary Sjögren's syndrome: clinical and immunological characteristicsM Ramos-Casals, R Cervera, J Font, et al.
Lupus|January 1, 1997
Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapyF J Muñoz-Rodríguez, J Font, J R Badia, et al.
Clinical and Experimental Immunology|December 22, 1999
Increased serum levels of soluble L-selectin (CD62L) in patients with active systemic lupus erythematosus (SLE)J Font, P Pizcueta, M Ramos-Casals, et al.
The Journal of Rheumatology|January 27, 2000
Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patientsJ Rojas-Rodriguez, M Garcia-Carrasco, M Ramos-Casals, et al.
QJM : Monthly Journal of the Association of Physicians|February 13, 2001
Cardiovascular risk factors and the long-term outcome of lupus nephritisJ Font, M Ramos-Casals, R Cervera, et al.
Annals of the Rheumatic Diseases|February 1, 1990
Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patientsR Cervera, J Font, A López-Soto, et al.
Pageof 38